Do you need an FSH test? Should your thyroid be checked? Is it time for a bone-density scan? Around menopause, it is tempting to look for a single “complete hormone panel”, but no universal set of blood tests can summarise this transition. A useful health check starts with age, symptoms, cycle pattern, medication, medical history and risk factors — then uses targeted tests to answer a specific question or guide prevention.
Key points
- After age 45, typical perimenopause and natural menopause usually do not require hormone testing for diagnosis.
- FSH and oestradiol fluctuate during the transition, so one result may be misleading.
- Tests should reflect symptoms and risk: possible anaemia, thyroid disease, diabetes, lipid changes or bone health.
- A bone-density scan is not routinely required for every woman at age 50.
- Blood pressure, recommended cancer screening, mental health and genitourinary health matter as much as blood tests.
Do you need a blood test to diagnose menopause?
Usually not. In women over 45 with typical symptoms and changing cycles, perimenopause is identified clinically. Menopause is then confirmed after 12 months without a period, provided there is no other cause.
This avoids creating false certainty from a single biological snapshot. During perimenopause, ovarian function varies: FSH may be raised one month and lower the next, while oestradiol can also fluctuate substantially.
When can hormone testing be useful?
Testing may be considered when it addresses a particular clinical situation, including:
- symptoms or absent periods before age 45;
- suspected primary ovarian insufficiency before age 40;
- unexplained absence of periods;
- bleeding patterns altered by medication or hormonal contraception;
- atypical symptoms requiring another diagnosis to be considered.
Depending on the situation, a clinician may request FSH — sometimes more than once — and other targeted tests. Interpretation depends on age, cycle timing, contraception, medication and symptoms.
Is AMH a “menopause test”?
Anti-Müllerian hormone is mainly used to assess ovarian reserve in selected fertility contexts. It cannot predict an individual woman’s menopause date accurately enough and does not diagnose perimenopause on its own. Testing without a clear indication may create more anxiety than useful information.
Which tests may be useful for specific symptoms?
The purpose of testing is often to identify another condition that could cause or worsen symptoms.
Fatigue or heavy periods: full blood count and ferritin
Heavier bleeding during perimenopause can contribute to iron deficiency, with or without anaemia. A full blood count and ferritin may be relevant when fatigue, breathlessness, palpitations, hair shedding, restless legs or heavy bleeding are present.
A low ferritin result should not simply lead to iron supplements; the reason for ongoing blood loss should also be assessed.
Non-specific symptoms: thyroid function
Fatigue, weight change, palpitations, anxiety, sleep disruption and irregular periods may also occur with thyroid disease. A thyroid-stimulating hormone (TSH) test may be appropriate based on symptoms, examination and history. Routine repeated testing without a clinical reason is rarely useful.
Metabolic health: glucose and HbA1c
Assessment of diabetes risk becomes increasingly important with age and changes in body composition. Fasting glucose or HbA1c may be appropriate depending on risk factors and national guidance. Results should be interpreted alongside family history, blood pressure, medication and lifestyle.
Cardiovascular health: blood pressure and lipids
A lipid profile may include total cholesterol, HDL, LDL and triglycerides. Additional markers may be discussed for selected women based on family history and overall risk, but no marker replaces a complete cardiovascular assessment.
Blood pressure is an essential health measure even though it does not require a blood sample. Smoking, diabetes, migraine with aura, pregnancy history, inflammatory disease, sleep and family history may also influence cardiovascular risk.
Vitamin D, calcium and other nutrients
Not every nutrient needs routine testing. Measurements should be based on diet, symptoms, reduced absorption, medication, medical conditions or bone risk. A result should never be interpreted without nutritional and clinical context.
Do you need a bone-density scan at menopause?
Not automatically. Dual-energy X-ray absorptiometry (DXA) measures bone mineral density and helps assess osteoporosis risk. It may be especially relevant with factors such as:
- a fracture after minimal trauma;
- primary ovarian insufficiency or early menopause;
- prolonged corticosteroid use or other bone-risk medication;
- low body weight, an eating disorder or malabsorption;
- family history of hip fracture;
- smoking, high alcohol intake or a condition associated with bone fragility.
Bone prevention also includes weight-bearing movement, strength training, adequate nutrition, balance work, falls prevention and stopping smoking.
Which screening should not be overlooked?
Prevention during the 45–55 age range is not limited to hormones. Timing depends on age, personal history and local screening programmes. Discuss:
- breast cancer screening;
- cervical cancer screening;
- bowel cancer screening;
- oral health and skin checks according to risk;
- vaccination status;
- mental health, sleep, substance use and safety;
- sexual and genitourinary health.
Bleeding after menopause is not a routine screening issue: it is a symptom that always requires assessment.
How can you prepare for a useful appointment?
For several weeks, record:
- dates, duration and heaviness of periods;
- hot flushes and night sweats;
- sleep and fatigue;
- mood, anxiety and concentration;
- headaches, pain and palpitations;
- vaginal, sexual or urinary symptoms;
- medication, contraception and supplements;
- relevant personal and family history.
Add your priorities: sleeping better, understanding fatigue, reducing hot flushes, discussing contraception, protecting bone health or considering treatment. The best health check is the one that supports a decision — not the one with the greatest number of markers.
How should results be interpreted?
A laboratory value must be read using the laboratory method and units, the clinical context and, where relevant, cycle timing. “Within range” does not necessarily explain why someone feels unwell, while an out-of-range result does not automatically mean disease.
Two shortcuts should be avoided:
- attributing every symptom to hormones;
- treating a number before confirming its relevance, repeatability and cause.
Good interpretation comes from connecting data rather than simply accumulating it.
What should be checked before menopausal hormone therapy?
The decision to start MHT is based first on symptoms, preferences and an individual assessment of benefits and risks. This includes age, time since menopause, whether the uterus is present, history of hormone-sensitive cancer, clotting and cardiovascular risk, blood pressure and appropriate screening.
There is no single compulsory test panel for every woman. Evaluation should match the individual, and treatment should then be reviewed regularly — at least annually according to French health guidance.
The OVEA perspective: test with purpose, understand in context
During perimenopause and after menopause, symptoms do not exist in isolation. Sleep, previous cycle patterns, metabolism, thyroid function, nutrients, cardiovascular health and personal history can intersect.
OVEA is building a preventive health assessment designed around women: carefully selected information connected with symptoms, history and lifestyle, then translated into understandable priorities. Join the waitlist to be among the first to discover OVEA.
Reviewed by the OVEA medical committee